Preventing MDROs

At a glance

Multidrug-resistant organisms (MDROs) are continuing to develop and spread in healthcare settings throughout the United States. Because of this, efforts to prevent MDRO transmission are still needed. In the past, MDROs were identified after lab confirmation, however, research has found that these organisms can spread long before being detected. A prevention approach that incorporates multiple healthcare facilities can potentially limit spread more effectively than response strategies alone.

Overview

CDC has developed two guides and FAQs for healthcare facilities, state, local, and territorial health departments to limit the spread of novel or targeted (e.g., Candida auris, carbapenemase-producing CRE) MDROs, FAQs, and a graphic (Figure 1) showing the relationship between prevention and response activities.

Comparison of strategies

View Larger
Figure 1. Relationship between epidemic stages, response tiers, containment response, and prevention activities for novel or targeted MDROs.
Figure 1. Relationship between epidemic st ages, response tiers, containment response, and prevention activities for novel or targeted MDROs.
Show More

MDRO Guide

Preventing MDROs: FAQs

FAQs for preventing multi-drug resistant organisms (MDROs).

MDRO Prevention Strategies

Prevention strategies against the spread of novel or targeted multidrug-resistant organisms (MDROs).

MDRO Containment Strategy

Containment strategies for novel or targeted multidrug-resistant organisms (MDROs).

What Can Be Done

Learn what can be done to prevent & contain novel or targeted multidrug-resistant organisms (MDROs).

Case Studies

Case studies of CDC’s MDRO Containment Strategy in action.

Technical appendix

Implementing Regional MDROs Prevention Bundles ─ Mathematical Modeling Methods and Findings

Implementing Regional MDROs Prevention Bundles ─ Mathematical Modeling Methods and Findings

Lab resources

Laboratory Resources for HAIs

Laboratory resources to detect HAIs and antimicrobial resistance.
AR Lab Network logo. A high-tech map of the United States with gradient colors of teal, blue, purple, dark red, red and orange-red.

Antimicrobial Resistance Laboratory Network

Resources about CDC's AR Lab Network for U.S. labs for quicker response to antimicrobial resistance.

Investigation guides and infection control assessments

Investigation and Control of Vancomycin- Resistant Staphylococcus aureus (VRSA): 2015 Update

Infection Control Assessment and Response (ICAR) Tool for General Infection Prevention and Control (IPC) Across Settings

Assess and improve a healthcare facility’s infection control and prevention practices.

Infection Control Basics

Infection control basics in healthcare include standard and transmission-based precautions.

Transmission-Based Precautions

Transmission-based precautions are used when patients already have confirmed or suspected infections...

Candida auris Infection Prevention

C. auris infection control in inpatient settings include diligent standard contact precautions, hand...

Considerations for Reducing Risk: Water in Healthcare Facilities

Healthcare facilities should consider these actions to reduce water-based health risks.

Colonization screenings

Antimicrobial Resistance Laboratory Networks

Antimicrobial resistance resources and testing information for laboratorians.

CDC Health Advisory: New Carbapenem-Resistant Enterobacteriaceae Warrant Additional Action by Healthcare Providers

CRE can cause infections in patients in hospitals.

About Carbapenem-resistant Enterobacterales

Carbapenem-resistant Enterobacterales (CRE) are germs resistant to one or several antibiotics called...

Screening FAQs: verbal consent example

Screening FAQs: verbal consent example (Spanish)

Screening FAQs: verbal consent example (Haitian creole)

Screening FAQs: verbal consent example (Vietnamese)

Screening FAQs: verbal consent example (simplified Chinese)

Inter-facility transfer form

Inter-Facility Infection Control Transfer Form for States Establishing HAI Prevention Collaboratives

Inter-Facility Infection Control Transfer Form for States Establishing HAI Prevention Collaboratives

MDRO resources

Laboratory Resources for HAIs

Laboratory resources to detect HAIs and antimicrobial resistance.

Candida auris General Information

Candida auris is an emerging fungus that presents a serious global health threat. Some strains of Ca...

CRE Carbapenem-resistant Enterobacterales Handout

CRPA Carbapenem-resistant Pseudomonas aeruginosa Handout

CRAB Carbapenem-resistant Acinetobacter baumannii Handout

Implementation of Personal Protective Equipment (PPE) Use in Nursing Homes to Prevent Spread of Multidrug-resistant Organisms (MDROs)

How to use PPE, infection control guidelines, and more to prevent MDROs.
Print
Content Source:
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)